Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit F pseudogene 2 (EIF3FP2)
- Target
- EIF3FP2
- Molecular classification
- Pseudogene, Non-coding RNA locus (when transcribed)
01
Overview
Eukaryotic translation initiation factor 3 subunit F pseudogene 2 (EIF3FP2, ENSG00000279081) is a genomic DNA segment highly homologous to the functional gene encoding eukaryotic translation initiation factor 3 subunit F (EIF3F), but due to mutations or disruptions (frameshifts, premature stop codons), it does not produce a functional protein product[2][6]. Pseudogenes may be transcribed as non-coding RNAs, which in rare cases might act as regulatory molecules (e.g., competing endogenous RNAs), but for EIF3FP2 specifically, no clear biological or disease role has been established[4]. Pseudogenes can sometimes complicate molecular genetic analyses due to similarity to their parent genes[6]. This locus is not considered a therapeutic target and has no documented direct interaction with drugs or known safety issues.
- Other names
- EIF3FP2eukaryotic translation initiation factor 3, subunit F pseudogene 2IFP38eukaryotic translation initiation factor 3 subunit 5 epsilon pseudogene
02
Mechanism of action
Not applicable (no protein product, no recognized direct drug targeting)
03
Biological functions
Potentially regulatory roles through non-coding RNAs (ceRNA activity, gene expression interference)No established direct physiological function as a protein
04
Disease associations
No documented direct disease associationsPseudogenes in general can play indirect roles in cancer or gene regulation through non-coding RNA mechanisms
Beyond the preview
Go deeper on Eukaryotic translation initiation factor 3 subunit F pseudogene 2 (EIF3FP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit F pseudogene 2 (EIF3FP2).